Sage Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sage Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1025% to $86,455,000. Profit margin reached -626%. Total operating expenses were $664,145,000.
Profit Margin
| 2014 | 0 | -33.81M | |
|---|---|---|---|
| 2015 | 0 | -94.49M | |
| 2016 | 0 | -158.98M | |
| 2017 | 0 | -270.12M | |
| 2018 | 90.27M | -372.88M | -413.06% |
| 2019 | 6.86M | -650.15M | -9466.38% |
| 2020 | 1.11B | 606.07M | 54.4% |
| 2021 | 6.30M | -450.82M | -7146.91% |
| 2022 | 7.68M | -503.26M | -6547.84% |
| 2023 | 86.45M | -541.48M | -626.32% |
SAGE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 86.45M | 7.68M | 6.30M | 1.11B | 6.86M | 90.27M | 0 | 0 | 0 | 0 |
Cost of revenue | 2.15M | 813K | 553K | 565K | 400K | 0 | 500K | 0 | 115K | 0 |
Gross profit | 84.29M | 6.87M | 5.75M | 1.11B | 6.46M | 90.27M | -500K | 0 | -115K | 0 |
Operating exp. | ||||||||||
Research and development | 356.23M | 326.16M | 283.16M | 292.71M | 368.81M | 282.10M | 210.27M | 120.75M | 69.35M | 24.1M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 44.59M | 11.17M | 5.26M | 3.07M | 0 |
Total operating expenses | 664.14M | 553.86M | 466.66M | 489.66M | 714.59M | 483.51M | 273.15M | 160.16M | 94.65M | 33.81M |
Operating income | -579.84M | -546.98M | -460.90M | 596.22M | -708.12M | -393.23M | -273.15M | -160.16M | -94.65M | -33.81M |
Other income (expenses), net | 38.36M | 14.20M | 3.01M | 9.84M | 27.88M | 22K | 3.03M | -35K | 155K | -1K |
Income before tax | -541.48M | -532.78M | -457.89M | 606.07M | -680.23M | -372.88M | -270.12M | -158.98M | -94.49M | -33.81M |
Income tax expense | 0 | -29.51M | -7.06M | 15.51M | -30.08M | 20.35M | -3.63M | -1.49M | -293K | -59K |
Net income | -541.48M | -503.26M | -450.82M | 606.07M | -650.15M | -372.88M | -270.12M | -158.98M | -94.49M | -33.81M |
Earnings per share | ||||||||||
Basic EPS | -9.05 | -8.49 | -7.68 | 11.66 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 |
Diluted EPS | -9.05 | -8.49 | -7.68 | 11.43 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |